Phyllanthostatin I

Drug Profile

Phyllanthostatin I

Alternative Names: NSC 328426; Phyllanthoside; Phyllanthostatin

Latest Information Update: 26 Oct 1994

Price : $50

At a glance

  • Originator National Cancer Institute (USA)
  • Class Antineoplastics; Antivirals
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 26 Oct 1994 NSC 328426's new name is phyllanthostatin I.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top